Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Stemline Therapeutics Inc (NASDAQ:STML)

9.45
Delayed Data
As of Apr 26
 +0.35 / +3.85%
Today’s Change
4.79
Today|||52-Week Range
14.60
-11.68%
Year-to-Date
No recent news for Stemline Therapeutics Inc.

Today’s Trading

Previous close9.10
Today’s open9.10
Day’s range9.00 - 9.45
Volume185,032
Average volume (3 months)343,271
Market cap$228.0M
Dividend yield--
Data as of 3:59pm ET, 04/26/2017

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)+8.37%
Earnings growth (next 5 years)--
Revenue growth (last year)+59.19%
P/E ratioNM
Price/Sales182.95
Price/Book3.03

Competitors

 Today’s
change
Today’s
% change
PETXAratana Therapeutics...+0.36+5.96%
NYMXNymox Pharmaceutical...+0.19+3.96%
ABEOAbeona Therapeutics ...+0.35+6.42%
KURAKura Oncology Inc-0.10-0.89%
Data as of 3:59pm ET, 04/26/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$1.0M
Annual profit (last year)-$38.3M
Net profit margin-3,678.19%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Ivan Bergstein
Chief Operating Officer &
Secretary
Kenneth Hoberman
Corporate headquarters
New York, New York

Forecasts


Search for Jobs